Sight Sciences, Inc. — Investor Relations & Filings

Sight Sciences, Inc. is an eyecare technology company that develops and commercializes interventional solutions for prevalent eye diseases. The company focuses on providing eyecare professionals with transformative, clinically-proven, and minimally invasive technologies. Its core products address the underserved markets of glaucoma and dry eye disease. The OMNI® Surgical System is a device used in minimally invasive glaucoma surgery (MIGS) to reduce intraocular pressure in adults with primary open-angle glaucoma. The TearCare® System is a tool for ophthalmologists and optometrists to apply localized heat for the treatment of meibomian gland dysfunction (MGD), a leading cause of evaporative dry eye disease. The company's mission is to transform the standard of care by enabling earlier and more effective interventions to preserve vision.